This med called Repotrectinib is aimed at treating ROS1-positive NSCLC and NTRK-fusion cancer types. It is categorized as a TRK/ROS1/ALK inhibitor, and operates by blocking specific kinases involved in cancer cell growth. And you can get it in these 40 mg capsule things.
You take it 160 mg, once a day, for the first 14 days, and then you up your dosage to 160 mg, two times a day, after that. And these capsules come in bottles with 60 units each.
